Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Photodynamic therapy with riboflavin-tryptophan gel versus 13% 5-aminolevulinic acid for mild to moderate acne vulgaris
TCTR20190907005Completed
- Start
- Mar 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of 5-aminolevulinic acid in acne vulgaris (2 arms), sponsored by none. Primary endpoints: Global Acne Assessment Score at week 7, Fluorescence photography at week 7 and 4 more. Started Mar 2017; status: completed.
02
Drugs
5-aminolevulinic acid
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on TCTR20190907005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20190907005.